• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Industrials·IONEXCHANG.NS
Share

Ion Exchange Stocks

₹ 444.2Last Updated 15.07.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

₹ 603.89M

₹ 444.2
Key Takeaways

Risk factor

Resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Good margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Ion Exchange (India) Limited, established in Mumbai in 1964, is a prominent provider of water treatment and environmental management solutions, serving clients both in India and internationally. Operating across its Engineering, Chemicals, and Consumer Products segments, the company offers a comprehensive portfolio. This includes advanced systems for raw water treatment, process and post-treatment, potable water purification, wastewater management, recycling, and zero liquid discharge, utilizing technologies like ion exchange, various membrane processes, and 3D modeling. Its product lines feature specialized resins (for catalyst, adsorbent, pharmaceutical, nuclear, and sugar refining applications), diverse water purification equipment, and a range of membranes (e.g., nanofiltration, ultrafiltration, and RO membranes for sea water, fouling-resistant, and brackish-resistant uses). The company also provides INDION specialty chemical programs for industrial water treatment (such as cooling and boiler water) and supplies sophisticated online monitoring and control instruments for water quality and effluent management. Beyond products, Ion Exchange offers extensive services including consultancy, design engineering, project financing, installation, commissioning, plant automation, rehabilitation, and ongoing operations and maintenance, along with operator training. Its broad customer base extends to various heavy industries (e.g., automotive, cement, power, chemicals, steel, food & beverage, pharmaceuticals), institutional clients (e.g., educational, hospitals, defense), municipal bodies, and both residential and commercial establishments.

Company Valuation

Slightly overvalued
3/7

From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of fair

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Slightly negative
3/7

The average target price of IONEXCHANG.NS is 448 and suggests 0.855% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral reco

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

17.07.2026 09:30

Berkshire Hathaway may have accelerated its share buyback. This was indicated in Buffett's documents

17.07.2026 08:30

Lilly to Acquire Psychedelic Drug Developer for $3.8 Billion. Are There Any Prospects?

17.07.2026 07:30

Netflix is expecting a slowdown in revenue growth for the second consecutive quarter. Its stock plummeted 8%.

17.07.2026 02:57

The release of Google's cutting-edge AI model has been delayed by months — Bloomberg. Shares fell

17.07.2026 01:40

Alphabet and other tech stocks dragged down the entire market: the Nasdaq index fell 1.5%

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026